S-1/A: First Choice Healthcare Solutions Files for Public Offering of Common Units and Pre-Funded Warrants

First Choice Healthcare Solutions is seeking to raise capital through a public offering of common units and pre-funded warrants to fund its strategic shift towards primary care and wellness clinics.

Summary

• First Choice Healthcare Solutions is offering up to 2,000,000 common units, each consisting of one common share, one Series A warrant, and one Series B warrant, at an assumed price of $5.00 per unit.
• The company is also offering pre-funded units, consisting of one pre-funded warrant, one Series A warrant, and one Series B warrant, to investors who would exceed a 4.99% beneficial ownership limit.
• The pre-funded warrants have a nominal exercise price of $0.01 per share and are immediately exercisable.
• The Series A warrants are exercisable at up to two times the public offering price and expire in five years, while the Series B warrants are exercisable at two times the public offering price and also expire in five years.
• The company intends to use the net proceeds from the offering for acquisitions, hiring key personnel, working capital, and marketing expenses.
• The company is also registering 3,317,500 shares of common stock for resale by existing stockholders, with 550,000 of these shares issuable upon the exercise of warrants.
• The company plans to list the common units on the New York Stock Exchange under the symbol FCHS.
• The company is pivoting from its historical orthopedic business model to a strategy of developing a national chain of primary care and wellness clinics.
• The company has acquired Pointe Medical Services and The Good Clinic, Inc. to support this new strategy.
• The company expects to commence operations for the primary care and wellness clinics as part of its new strategy starting March 1, 2025.

Sentiment

Score: 4

Explanation: While the company has a clear strategy and is entering a growing market, the financial history and risks associated with the business model temper the overall sentiment. The company is also facing significant competition.

Positives

• The company is pivoting to a high growth market of primary care and wellness clinics.
• The company has acquired assets to support its new strategy.
• The company has a clear plan for the use of proceeds from the offering.
• The company is seeking a listing on the NYSE which may increase liquidity and visibility.
• The company is offering a suite of services that are typically reimbursed by insurance.

Negatives

• The company has a limited operating history in the primary care and wellness clinic space.
• The company has a history of net losses and negative cash flows.
• The company is subject to significant competition in the healthcare market.
• The company is subject to numerous risks related to its financial position and capital needs.
• The company is subject to numerous risks related to its healthcare services business.

Risks

• The company has a limited operating history that impedes its ability to evaluate its potential future performance and strategy.
• The company may not be able to achieve the expected benefits from opening new primary care clinics, which would adversely affect its financial condition and results.
• If the company is unable to attract and retain qualified medical professionals, its ability to maintain operations attract patients or open new primary care clinics could be negatively affected.
• The company may have difficulties managing its growth, which could lead to higher operating losses, or it may not grow at all.
• The company may be subject to medical professional liability risks, which could be costly and could negatively impact its business and financial results.
• The healthcare industry is highly regulated, and government authorities may determine that the company has failed to comply with applicable laws or regulations.
• The company's primary clinics will be based primarily on the self-pay model, which could lead to fewer patients utilizing these services or the need for the company to discount such services, which could limit its growth and negatively impact its operations.
• Changes in the rates or methods of third-party reimbursements for medical services could result in reduced demand for the company's services or create downward pricing pressure, which would result in a decline in its revenues and harm its financial position.
• The market for healthcare services is highly competitive.
• The company is a smaller reporting company and it cannot be certain if the reduced disclosure requirements applicable to smaller reporting companies will make its common stock less attractive to investors.
• The market for the company's common stock may fluctuate significantly.
• A significant percentage of the company's common stock is held by a small number of shareholders.
• The issuance of the company's common stock in connection with the company's outstanding convertible preferred stock and warrants could cause substantial dilution, which could materially affect the trading price of its common stock.
• Resales by the selling stockholders under the Resale Prospectus may have an adverse effect on the market price of the company's Common Stock.
• The company has not paid dividends in the past and has no immediate plans to pay dividends.
• Penny stock rules may make buying or selling the company's securities difficult which may make its stock less liquid and make it harder for investors to buy and sell its securities.
• The company's former Chief Executive officer, Christian C. Romandetti, Sr., was arrested November 15, 2018, on a conspiracy to commit securities fraud charge.
• The company's charter documents and Delaware law may inhibit a takeover that stockholders consider favorable.
• Failure to achieve and maintain internal controls in accordance with Sections 302 and 404 of the Sarbanes-Oxley Act of 2002 could have a material adverse effect on the company's business and stock price.

Future Outlook

The company expects to commence operations for the primary care and wellness clinics as part of its new strategy starting March 1, 2025.

Management Comments

• The company is actively engaged in pivoting the Companys strategy away from our historic orthopedic business model to a strategy of developing a national chain of innovative primary care and wellness clinics.
• Our strategic commitment is to provide a more effective medical home by redefining primary care, through personalization of care and a broad spectrum of healthcare services that focus on improving the quality of life for our clients at every stage of their lives.

Industry Context

The company is operating in a fragmented healthcare market with direct and indirect competitors that offer varying levels of systemic medical services. The market for healthcare solutions including primary care clinics, online medical providers and compounding pharmacies is highly competitive.

Comparison to Industry Standards

• The company faces competition from virtual competitors like Hims, Ro, REX MD, and Renew Youth for men's health, and Alloy and Midi for women's health.
• The company also competes with brick and mortar clinics such as Revibe, Herself Health, Oak Street Medical, and One Medical.
• The company's financial success is contingent on its ability to address the needs of patients efficiently and with superior service experience and medical outcomes compared to its competitors.
• The company's strategy of combining a full suite of primary care services with specialized services and an internal compounding pharmacy is intended to deliver better healthcare experiences and greater revenue opportunities.

Management Changes

Legal Proceedings

• The company's former Chief Executive Officer, Christian C. Romandetti, Sr., was arrested November 15, 2018, on a conspiracy to commit securities fraud charge.
• The company and its operating subsidiaries filed for bankruptcy on June 15, 2020.
• The company's reorganization plan related to the bankruptcy was confirmed on February 22, 2021.
• The company exited bankruptcy on April 27, 2022.

Stakeholder Impact

• Shareholders will experience dilution from the offering and potential future conversions of preferred stock and warrants.
• Employees may benefit from the company's growth and expansion.
• Customers will have access to a new model of primary care and wellness services.
• Suppliers may benefit from increased business with the company.
• Creditors may be impacted by the company's financial performance and ability to repay debts.

Next Steps

• The company plans to complete the acquisitions of PointeMed Pharmacy and The Good Clinic, Inc. immediately after the closing of the offering.
• The company expects to commence operations for the primary care and wellness clinics as part of its new strategy starting March 1, 2025.

Key Dates

Keywords

primary care, wellness clinics, healthcare services, compounding pharmacy, regenerative medicine, hormone replacement therapy, medical weight management, public offering, common units, pre-funded warrants